Literature DB >> 1968229

Interaction between neuropeptide Y and noradrenaline on central catecholamine neurons.

P Illes1, J T Regenold.   

Abstract

Despite their widespread occurrence in the central nervous system, interactions between co-localized transmitters and their receptors remain poorly understood. Noradrenergic neurons of the nucleus locus coeruleus contain the peptide co-transmitter neuropeptide Y (refs 1,2). In locus coeruleus cells, stimulation of alpha2-adrenoceptors 3,4 or opioid mu-receptors 5,6 increases a potassium conductance and thereby leads to hyperpolarization and inhibition of spontaneous firing. Coupling between these receptors and the inward rectifying K+ channels involves a pertussis toxin-sensitive GTP-binding protein (Gi or Go)7. Here we investigate whether the neuropeptide Y and alpha2-receptors of locus coeruleus neurons interact with one another. When administered alone, neuropeptide Y reduces the discharge of action potentials, probably by increasing the permeability of the membrane to potassium ions through the activation of a G protein; this effect is reduced in the presence of alpha2-adrenoceptor antagonists. Moreover, the peptide selectively increases the hyperpolarizing effect of alpha2-agonists, but does not enhance responses to opioid mu-agonists. We suggest that noradrenaline and its co-transmitter neuropeptide Y stimulate separate receptors, which influence each other in a specific way.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968229     DOI: 10.1038/344062a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  15 in total

1.  Receptor recruitment: a mechanism for interactions between G protein-coupled receptors.

Authors:  U Holtbäck; H Brismar; G F DiBona; M Fu; P Greengard; A Aperia
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 2.  Interaction of P2 purinergic receptors with cellular macromolecules.

Authors:  Laszlo Köles; Zoltan Gerevich; João Felipe Oliveira; Zoltan Sandor Zadori; Kerstin Wirkner; Peter Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-19       Impact factor: 3.000

3.  Contraction-mediating alpha 2-adrenoceptors in the mouse vas deferens.

Authors:  R Bültmann; I von Kügelgen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

4.  Genetic comparison of seizure control by norepinephrine and neuropeptide Y.

Authors:  D Weinshenker; P Szot; N S Miller; N C Rust; J G Hohmann; U Pyati; S S White; R D Palmiter
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

Review 5.  Molecular pathways of anxiety revealed by knockout mice.

Authors:  S J Wood; M Toth
Journal:  Mol Neurobiol       Date:  2001 Apr-Jun       Impact factor: 5.590

6.  Inhibition of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells by Y3-type neuropeptide Y receptors via the adenylate cyclase/protein kinase A system.

Authors:  W Nörenberg; M Bek; N Limberger; K Takeda; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

7.  The effects of sigma ligands on the release of glutamate from rat striatal slices.

Authors:  Y Ellis; J A Davies
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

Review 8.  Regulation of neuropeptide expression in the brain by neurotrophins. Potential role in vivo.

Authors:  J Carnahan; H Nawa
Journal:  Mol Neurobiol       Date:  1995 Apr-Jun       Impact factor: 5.590

9.  Blockade of alpha 2-adrenoceptors increases opioid mu-receptor-mediated inhibition of the firing rate of rat locus coeruleus neurones.

Authors:  P Illes; W Nörenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-11       Impact factor: 3.000

10.  Depression by neuropeptide Y of noradrenergic inhibitory postsynaptic potentials of locus coeruleus neurones.

Authors:  E P Finta; J T Regenold; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.